Cargando…

262 Safety and efficacy of the COVID-19 vaccine among fully vaccinated and boosted skin cancer patients

Detalles Bibliográficos
Autores principales:	Raiker, R., Pakhchanian, H., Deng, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296916/ http://dx.doi.org/10.1016/j.jid.2022.05.269

Ejemplares similares

35399 Examining the safety and efficacy of COVID-19 vaccination among atopic dermatitis patients
por: Pakhchanian, Haig, et al.
Publicado: (2022)

265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients
por: Pakhchanian, H., et al.
Publicado: (2022)

LB766 Prevalence and adverse events of special interest among COVID19-vaccinated patients with chronic inflammatory skin diseases: An early look
por: Raiker, R., et al.
Publicado: (2021)

COVID-19 vaccination outcomes among patients with dermatomyositis: a multicentered analysis
por: Pakhchanian, Haig, et al.
Publicado: (2022)

331 Trends and outcomes in patients with malignant skin cancers during the COVID pandemic
por: Raiker, R., et al.
Publicado: (2021)

35304 Safety and efficacy of COVID-19 vaccination in psoriasis patients
por: Baker, Mairead, et al.
Publicado: (2022)

Who has not been vaccinated, fully vaccinated, or boosted for COVID-19?
por: Nguyen, Kimberly H., et al.
Publicado: (2022)

COVID-19 among patients with Behçet syndrome in the United States
por: Pakhchanian, Haig, et al.
Publicado: (2021)

35309 COVID-19 outcomes among patients with cutaneous T-cell lymphoma: A multicentered analysis
por: Baker, Mairead, et al.
Publicado: (2022)

LB768 Adult and pediatric emergency department visits for dermatological conditions during the COVID-19 pandemic: A multicenter analysis
por: Pakhchanian, H., et al.
Publicado: (2021)

LB751 COVID-19 complications in patients with Hidradenitis Suppurativa: A multicenter study
por: Raiker, R., et al.
Publicado: (2021)

342 Clinical outcomes in COVID-19 patients with Atopic dermatitis
por: Pakhchanian, H., et al.
Publicado: (2021)

254 COVID-19 related outcomes in psoriasis and psoriasis arthritis patients
por: Raiker, R., et al.
Publicado: (2021)

205 COVID-19 complications in vitiligo patients: A multicenter study
por: Raiker, R., et al.
Publicado: (2022)

TH-262. Risk and characteristics of Bell’s palsy as an adverse event following COVID-19 vaccination
por: Kim, Sohyeon, et al.
Publicado: (2022)

LB767 A multicenter analysis of patients using telemedicine for dermatological conditions during the COVID-19 pandemic
por: Raiker, R., et al.
Publicado: (2021)

LB761 Clinical outcomes in Pemphigoid and Pemphigus patients with COVID-19
por: Pakhchanian, H., et al.
Publicado: (2021)

338 Clinical outcomes in COVID-19 patients with dermatopolymyositis
por: Pakhchanian, H., et al.
Publicado: (2021)

COVID-19 Vaccine Booster: To Boost or Not to Boost
por: Shekhar, Rahul, et al.
Publicado: (2021)

Reply to “Letter to the Editor Regarding ‘COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis’”
por: Pakhchanian, H, et al.
Publicado: (2023)

255 The risk of contracting COVID-19 after dermatological procedures compared with other medical procedures
por: Raiker, R., et al.
Publicado: (2021)

243 Clinical outcomes in COVID-19 patients with varicella zoster virus
por: Raiker, R., et al.
Publicado: (2021)

Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel
por: Maltezou, H.C., et al.
Publicado: (2023)

An analysis of fatal adverse conditions in temporal association of COVID-19 vaccination to boost the safety of vaccination for COVID-19
por: Muslim, Shahnawaz, et al.
Publicado: (2023)

Burden of Thrombotic Events in Coronavirus Disease-19 (COVID-19) Patients and Effect on Outcomes (from a Multicenter Electronic Health Record Database)
por: Mukherjee, Amrita, et al.
Publicado: (2021)

Reduced protective efficacy of hepatitis B vaccine among fully vaccinated children in Ethiopia
por: Adugna, Adane, et al.
Publicado: (2023)

COVID-19’s impact on interest in gastrointestinal topics
por: Yan, Michael B., et al.
Publicado: (2022)

Efficacy and safety of COVID‐19 vaccines
por: Graña, Carolina, et al.
Publicado: (2022)

OP 262-338
Publicado: (2005)

Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends
por: Kardeş, Sinan, et al.
Publicado: (2020)

Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends
por: Kardeş, Sinan, et al.
Publicado: (2020)

Reply to “Pityriasis rosea during COVID-19 and its pathogenesis”
por: Nussbaum, Dillon, et al.
Publicado: (2022)

Public Interest in Refractive Diseases and Treatments During the COVID-19 Pandemic: A Google Trends Analysis
por: Gupta, Rishabh, et al.
Publicado: (2021)

Patients with post-COVID-19 vaccination facial palsy: To boost or not to boost?
por: Cirillo, Nicola, et al.
Publicado: (2022)

Heterologous prime boost COVID 19 vaccination
por: Launay, O., et al.
Publicado: (2022)

Pasteur, Vaccines, and the Refusal to Become Fully Vaccinated in the Midst of the COVID-19 Pandemic
por: Pavia, Charles S.
Publicado: (2022)

Efficacy and Safety of COVID-19 Vaccines—An Update
por: Sharma, Eshani, et al.
Publicado: (2022)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022)

Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology
por: Nussbaum, Dillon, et al.
Publicado: (2022)

Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network
por: Raiker, Rahul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0kbe8cjdsm42ehogsh7bt86flg